These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9031578)

  • 1. Combined pharmacotherapy in children and adolescents in a residential treatment center.
    Connor DF; Ozbayrak KR; Kusiak KA; Caponi AB; Melloni RH
    J Am Acad Child Adolesc Psychiatry; 1997 Feb; 36(2):248-54. PubMed ID: 9031578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overt categorical aggression in referred children and adolescents.
    Connor DF; Melloni RH; Harrison RJ
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):66-73. PubMed ID: 9444902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychiatric support for children and adolescents in residential care in a German sample].
    Nützel J; Schmid M; Goldbeck L; Fegert JM
    Prax Kinderpsychol Kinderpsychiatr; 2005 Oct; 54(8):627-44. PubMed ID: 16231595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment.
    Connor DF; Ozbayrak KR; Harrison RJ; Melloni RH
    J Child Adolesc Psychopharmacol; 1998; 8(1):27-38. PubMed ID: 9639077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
    Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
    Grolleau A; Cougnard A; Bégaud B; Verdoux H
    Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
    Deurell M; Weischer M; Pagsberg AK; Labianca J
    Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparison of behavioral and emotional symptoms in German residential care and day-care child welfare institutions].
    Schmid M; Nützel J; Fegert JM; Goldbeck L
    Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):544-58. PubMed ID: 17058780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric psychopharmacology for the major psychiatric disorders found in the residential treatment setting.
    Shoaf TL
    Child Adolesc Psychiatr Clin N Am; 2004 Apr; 13(2):327-45. PubMed ID: 15062349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
    Seng JS; Graham-Bermann SA; Clark MK; McCarthy AM; Ronis DL
    Pediatrics; 2005 Dec; 116(6):e767-76. PubMed ID: 16322133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral symptoms in residential care/assisted living facilities: prevalence, risk factors, and medication management.
    Gruber-Baldini AL; Boustani M; Sloane PD; Zimmerman S
    J Am Geriatr Soc; 2004 Oct; 52(10):1610-7. PubMed ID: 15450035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
    Fontanella CA; Bridge JA; Campo JV
    Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric resident and attending diagnostic and prescribing practices.
    Tripp AC; Schwartz TL
    Acad Psychiatry; 2008; 32(3):214-7. PubMed ID: 18467478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the pharmacotherapy of aggression in children and adolescents.
    Stewart JT; Myers WC; Burket RC; Lyles WB
    J Am Acad Child Adolesc Psychiatry; 1990 Mar; 29(2):269-77. PubMed ID: 2182611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
    Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
    J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.